[Peripheral arterial disease]
- PMID: 37757886
- DOI: 10.1055/a-2009-6072
[Peripheral arterial disease]
Conflict of interest statement
Abbott Vascular, Amarin, Amgen, Bayer Health Care, Boehringer Ingelheim, Bristol-Myers Squibb, Cordis, Daiichi Sankyo, Novartis, Pfizer, Sanofi-Aventis
Similar articles
-
Approach to the patient with peripheral arterial disease.Circulation. 2013 Nov 12;128(20):2241-50. doi: 10.1161/CIRCULATIONAHA.113.000502. Circulation. 2013. PMID: 24218439 Review. No abstract available.
-
Peripheral arterial disease: diagnosis and management.Nurs Times. 2012 Oct 30-Nov 5;108(44):23. Nurs Times. 2012. PMID: 23243805 No abstract available.
-
MY APPROACH to detecting and managing peripheral artery disease.Trends Cardiovasc Med. 2015 Jul;25(5):469-70. doi: 10.1016/j.tcm.2014.10.028. Epub 2015 Apr 23. Trends Cardiovasc Med. 2015. PMID: 25983072 No abstract available.
-
Progress in peripheral arterial disease.Prog Cardiovasc Dis. 2021 Mar-Apr;65:1. doi: 10.1016/j.pcad.2021.03.006. Epub 2021 Mar 22. Prog Cardiovasc Dis. 2021. PMID: 33766655 No abstract available.
-
Screening for peripheral artery disease.Semin Roentgenol. 2015 Apr;50(2):139-47. doi: 10.1053/j.ro.2014.10.011. Epub 2014 Oct 18. Semin Roentgenol. 2015. PMID: 25770344 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical